Treatment of Giant and Large Internal Carotid Artery Aneurysms With a High-Flow Replacement Bypass Using the Excimer Laser-Assisted Nonocclusive Anastomosis Technique

医学 吻合 颈内动脉 外科 动脉瘤 搭桥手术 并发症 改良兰金量表 推导 外科吻合 放射科 动脉 心脏病学 缺血 缺血性中风
作者
Tristan P. C. van Doormaal,Albert van der Zwan,Bon H. Verweij,David J. Langer,Cornelis A.F. Tulleken
出处
期刊:Operative Neurosurgery [Oxford University Press]
卷期号:59 (suppl_4): ONS-335 被引量:69
标识
DOI:10.1227/01.neu.0000233971.08409.f0
摘要

Abstract OBJECTIVE: To define the clinical value of the high-flow replacement bypass using the excimer laser-assisted nonocclusive anastomosis technique in the treatment of patients with a noncoilable, nonclippable giant or large intracranial aneurysm of the internal carotid artery (ICA). METHODS: We studied 34 patients with a giant intracranial aneurysm of the ICA proximal to its bifurcation who were treated with an extracranial-intercranial high-flow replacement bypass in our hospital between 1999 and 2004. We retrospectively collected data for patient characteristics, operative aspects, complications, and functional health scores using the modified Rankin scale. Long-term data were updated by questionnaire and telephone survey. Mean long-term follow-up period was 3.3 years (range, 0.6-5.6 yr). RESULTS: We were able to construct a patent bypass in 33 out of 34 patients (97%). In six patients (17%), we needed two bypass attempts. In one patient (3%), the bypass was technically impossible. After bypass construction, we occluded the ICA during or after surgery in 32 patients (94%), causing aneurysm thrombosis in all of these patients. A fatal complication occurred in two patients (6%) before we could occlude the ICA. A nonfatal complication occurred in seven patients (21%). In the long term, 25 patients (74%) had a favorable outcome and 27 patients (79%) were independent (modified Rankin scale, <3). CONCLUSION: This study shows that the excimer laser-assisted nonocclusive anastomosis high-flow replacement bypass, which provides maximum brain protection because of its nonocclusive character, is a reliable and effective method to treat these otherwise untreatable patients.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
刚刚
ncsxcb关注了科研通微信公众号
1秒前
小白发布了新的文献求助10
1秒前
1秒前
骆钧发布了新的文献求助10
2秒前
2秒前
科研通AI6.1应助健壮不斜采纳,获得10
2秒前
2秒前
3秒前
BBB完成签到,获得积分10
3秒前
无问西东发布了新的文献求助10
3秒前
OrangeLight完成签到,获得积分10
4秒前
宫宛儿完成签到,获得积分10
4秒前
无情采文发布了新的文献求助10
4秒前
迅速路人完成签到 ,获得积分10
5秒前
77发布了新的文献求助10
6秒前
王小能发布了新的文献求助10
6秒前
7秒前
雨眠Rainie发布了新的文献求助10
7秒前
隐形曼青应助coolplex采纳,获得10
7秒前
9秒前
10秒前
情怀应助givemesecondi采纳,获得10
10秒前
xu发布了新的文献求助10
10秒前
魔幻东冬完成签到,获得积分10
10秒前
coolplex发布了新的文献求助10
12秒前
12秒前
sscjl应助年轻的跳跳糖采纳,获得10
13秒前
小蘑菇应助风清扬采纳,获得10
13秒前
13秒前
Ava应助苏78采纳,获得10
13秒前
善良的冰颜完成签到 ,获得积分10
13秒前
骆钧完成签到,获得积分10
14秒前
蟹治猿完成签到 ,获得积分10
14秒前
14秒前
SciGPT应助123采纳,获得10
14秒前
李桢发布了新的文献求助10
15秒前
15秒前
15秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Kinesiophobia : a new view of chronic pain behavior 2000
Research for Social Workers 1000
Psychology and Work Today 800
Mastering New Drug Applications: A Step-by-Step Guide (Mastering the FDA Approval Process Book 1) 800
Kinesiophobia : a new view of chronic pain behavior 600
Signals, Systems, and Signal Processing 510
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 计算机科学 有机化学 物理 生物化学 纳米技术 复合材料 内科学 化学工程 人工智能 催化作用 遗传学 数学 基因 量子力学 物理化学
热门帖子
关注 科研通微信公众号,转发送积分 5896073
求助须知:如何正确求助?哪些是违规求助? 6708410
关于积分的说明 15732974
捐赠科研通 5018614
什么是DOI,文献DOI怎么找? 2702586
邀请新用户注册赠送积分活动 1649321
关于科研通互助平台的介绍 1598539